EMA has published its draft ‘Regulatory Science to 2025’ strategy for a six-month public consultation. This is a proposed plan for advancing the Agency’s engagement with regulatory science over the next five to ten years, covering both human and veterinary medicines.
The strategy will help shape the vision for the next EU Medicines Agencies Network Strategy (2020–2025). It seeks to offer informed guidance on modern medicines development, facilitate the optimisation of regulatory science and critically assess the benefits and risks of innovative therapies and diagnostics based on new technologies.
We are inviting all our stakeholders to send their comments via an online questionnaire by 30 June 2019.
As an EMA eligible stakeholder organisation we are particularly interested in receiving your input to this consultation. We would also appreciate your support in further cascading information about this consultation amongst your networks.
You can read more about the public consultation in the press release.